Mitophagy

Last updated

Mitophagy is the selective degradation of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. The process of mitophagy was first described over a hundred years ago by Margaret Reed Lewis and Warren Harmon Lewis. [1] Ashford and Porter used electron microscopy to observe mitochondrial fragments in liver lysosomes by 1962, [2] and a 1977 report suggested that "mitochondria develop functional alterations which would activate autophagy." [3] The term "mitophagy" was in use by 1998. [4]

Contents

Mitophagy is key in keeping the cell healthy. It promotes turnover of mitochondria and prevents accumulation of dysfunctional mitochondria which can lead to cellular degeneration. It is mediated by Atg32 (in yeast) and NIX and its regulator BNIP3 in mammals. Mitophagy is regulated by PINK1 and parkin proteins. In addition to the selective removal of damaged mitochondria, mitophagy is also required to adjust mitochondrial numbers to changing cellular metabolic needs, for steady-state mitochondrial turnover, and during certain cellular developmental stages, such as during cellular differentiation of red blood cells. [5]

Role

Organelles and bits of cytoplasm are sequestered and targeted for degradation by the lysosome for hydrolytic digestion by a process known as autophagy. Mitochondria metabolism leads to the creation of by-products that lead to DNA damage and mutations. Therefore, a healthy population of mitochondria is critical for the well-being of cells. Previously it was thought that targeted degradation of mitochondria was a stochastic event, but accumulating evidence suggest that mitophagy is a selective process. [6]

Generation of ATP by oxidative phosphorylation leads to the production of various reactive oxygen species (ROS) in the mitochondria, and submitochondrial particles. Formation of ROS as a mitochondrial waste product will eventually lead to cytotoxicity and cell death. Because of their role in metabolism, mitochondria are very susceptible to ROS damage. Damaged mitochondria cause a depletion in ATP and a release of cytochrome c, which leads to activation of caspases and onset of apoptosis. Mitochondrial damage is not caused solely by oxidative stress or disease processes; normal mitochondria will eventually accumulate oxidative damage hallmarks overtime, which can be deleterious to mitochondria as well as to the cell. These faulty mitochondria can further deplete the cell of ATP, increase production of ROS, and release proapoptopic proteins such as caspases.

Because of the danger of having damaged mitochondria in the cell, the timely elimination of damaged and aged mitochondria is essential for maintaining the integrity of the cell. This turnover process consists of the sequestration and hydrolytic degradation by the lysosome, a process also known as mitophagy.

Mitochondrial depletion reduces a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. [7]

Pathways

In mammals

There are several pathways by which mitophagy is induced in mammalian cells. The PINK1 and Parkin pathway is, so far, the best characterized. This pathway starts by deciphering the difference between healthy mitochondria and damaged mitochondria. A 64-kDa protein, PTEN-induced kinase 1 (PINK1), has been implicated to detect mitochondrial quality. PINK1 contains a mitochondrial targeting sequence (MTS) and is recruited to the mitochondria. In healthy mitochondria, PINK1 is imported through the outer membrane via the TOM complex, and partially through the inner mitochondrial membrane via the TIM complex, so it then spans the inner mitochondrial membrane. The process of import into the inner membrane is associated with the cleavage of PINK1 from 64-kDa into a 60-kDa form. PINK1 is then cleaved by PARL into a 52-kDa form. This new form of PINK1 is degraded by proteases within the mitochondria. This keeps the concentration of PINK1 in check in healthy mitochondria. [8]

In unhealthy mitochondria, the inner mitochondrial membrane becomes depolarized. This membrane potential is necessary for the TIM-mediated protein import. In depolarized mitochondria, PINK1 is no longer imported into the inner membrane, is not cleaved by PARL and PINK1 concentration increases in the outer mitochondrial membrane. PINK1 can then recruit Parkin, a cytosolic E3 ubiquitin ligase. [9] It is thought that PINK1 phosphorylates Parkin ubiquitin ligase at S65 which initiates Parkin recruitment at the mitochondria. [10] [11] The phosphorylation site of Parkin, at S65, is homologous to the site where ubiquitin is phosphorylated. This phosphorylation activates Parkin by inducing dimerization, an active state. [ citation needed ] This allows for Parkin-mediated ubiquitination on other proteins. [10]

Because of its PINK1-mediated recruitment to the mitochondrial surface, Parkin can ubiquitylate proteins in the outer mitochondrial membrane. [12] Some of these proteins include Mfn1/Mfn2 and mitoNEET. [11] The ubiquitylation of mitochondrial surface proteins brings in mitophagy initiating factors. Parkin promotes ubiquitin chain linkages on both K63 and K48. K48 ubiquitination initiates degradation of the proteins, and could allow for passive mitochondrial degradation. K63 ubiquitination is thought to recruit autophagy adaptors LC3/GABARAP which will then lead to mitophagy. It is still unclear which proteins are necessary and sufficient for mitophagy, and how these proteins, once ubiquitylated, initiate mitophagy.

Other pathways that can induce mitophagy includes mitophagy receptors on the outer mitochondrial membrane surface. These receptors include NIX1, BNIP3 and FUNDC1. All of these receptors contain LIR consensus sequences that bind LC3/GABARAP which can lead to the degradation of the mitochondria. In hypoxic conditions BNIP3 is upregulated by HIF1α. BNIP3 is then phosphorylated at its serine residues near the LIR sequence which promotes LC3 binding. FUNDCI is also hypoxia sensitive, although it is constitutively present at the outer mitochondrial membrane during normal conditions. [10] Mitophagy can also be artificially introduced by a series of synthetic autophagy receptors [13] that are composed of antibody fragments to recognize the mitochondrial outer membrane proteins. [14]

In neurons, mitochondria are distributed unequally throughout the cell to areas where energy demand is high, like at synapses and Nodes of Ranvier. This distribution is maintained largely by motor protein-mediated mitochondrial transport along the axon. [15] While neuronal mitophagy is thought to occur primarily in the cell body, it also occurs locally in the axon at sites distant from the cell body; in both the cell body and the axon, neuronal mitophagy occurs via the PINK1-Parkin pathway. [16] Mitophagy in the nervous system may also occur transcellularly, where damaged mitochondria in retinal ganglion cell axons can be passed to neighboring astrocytes for degradation. [17] This process is known as transmitophagy.

In yeast

Mitophagy in yeast was first presumed after the discovery of Yeast Mitochondrial Escape genes (yme), specifically yme1. Yme1 like other genes in the family showed increase escape of mtDNA, but was the only one that showed an increase in mitochondrial degradation. Through work on this gene which mediates the escape of mtDNA, researchers discovered that mitochondrial turnover is triggered by proteins. [18]

More was discovered about genetic control of mitophagy after studies on the protein UTH1. After performing a screen for genes that regulate longevity, it was found in ΔUTH1 strains that there was an inhibition of mitophagy, which occurred without affecting autophagy mechanisms. This study also showed that the Uth1p protein is necessary to move mitochondria to the vacuole. This suggested there is a specialized system for mitophagy. Other studies looked at AUP1, a mitochondrial phosphatase, and found Aup1 marks mitochondria for elimination. [18]

Another yeast protein associated with mitophagy is a mitochondrial inner membrane protein, Mdm38p/Mkh1p. This protein is part of the complex that exchanges K+/H+ ions across the inner membrane. Deletions in this protein causes swelling, a loss of membrane potential, and mitochondrial fragmentation. [18]

Recently, it has been shown that ATG32 (autophagy related gene 32) plays a crucial role in yeast mitophagy. It is localized to the mitochondria. Once mitophagy is initiated, Atg32 binds to Atg11 and the Atg32-associated mitochondria are transported to the vacuole. Atg32 silencing stops recruitment of autophagy machinery and mitochondrial degradation. Atg32 is not necessary for other forms of autophagy. [19] [20]

All of these proteins likely play a role in maintaining healthy mitochondria, but mutations have shown that dysregulation can lead to a selective degradation of mitochondria. Whether these proteins work in concert, are main players in mitophagy, or members in a larger network to control autophagy still remains to be elucidated.

Role in the immune response

Mitochondria play an important role in the functioning of the immune system. Mitochondrial damage-associated molecular patterns (DAMPs) such as parts of damaged organelles or mtDNA are secreted by cells following sterile inflammation, dysregulations in cell metabolism, or infection. There is evidence that these DAMPs act as one of the key triggers of the innate immune response. Mitophagy provides the elimination of non-functioning mitochondria and maintains mitochondrial homeostasis. Due to that, it can be seen as an immunomodulatory tool to keep the immune response in check. [21]

Hematopoiesis

In addition to immunomodulatory functions, mitophagy can regulate the fate of hematopoietic stem cells (HSC). Mitophagy impaired due to the deletion of autophagy-related genes led to a loss of HSC function, more likely as a result of mitochondrial damage that stimulated excessive ROS production. On the contrary, mitophagy induction appeared to be protective for HSC and directed stem cell differentiation to the myeloid lineage. [22]

Macrophages

Immune cell activation and the change in phenotype are followed by metabolic reprogramming. Activated cells, including macrophages, favor glycolysis, which is also accompanied by mitochondrial clearance through mitophagy. On the contrary, macrophage regulatory phenotypes (M2) are associated with the induction of oxidative phosphorylation, which is dependent on mitochondrial biogenesis. [23] This highlights the important role of mitophagy in the determination of the macrophage phenotype.

It is also important to mention that mitophagy impairment in macrophages is quite common in the early stages of different pathological states. Macrophages play an important role in the innate immune response. However, conditions leading to immune paralysis, e.g. sepsis, make them incapable of efficient bactericidal clearance. Hence, some studies highlighted the role of mitophagy as a biomarker of different stages of sepsis, as it is inhibited in the early stage and induced later. [24] Other reports showed compromised mitophagy in experimental and human kidney fibrosis. Some mitophagy-associated molecules such as Mfn2 and Parkin are negatively regulated in this pathological state. Consequently, the frequency of regulatory profibrotic M2 macrophages was higher, confirming the role of mitophagy in the induction of the pro-inflammatory M1 phenotype. [24] [25]

Inflammasome

Many studies demonstrate that the release of mtROS and mtDNA as DAMPs plays a crucial role in the activation of the inflammasome and following inflammation mediated by IL-1β. NF-κB, a protein complex that is important for immune cell signaling, but also plays an important role in mitophagy induction, has been reported to control the activation of the inflammasome by adopting the p62-mitophagy pathway. [26]

The importance of mitophagy was demonstrated by the deletion of Beclin 1 and LC3b autophagy-associated genes in bone marrow-derived macrophages (BMDM). Defective mitophagy and accumulation of damaged mitochondria led to enhanced mtROS production and the release of cytosolic mtDNA. As a result, activation of the NLRP3 inflammasome increased. [26] Recently, it was shown that Parkin deficiency also triggered NLRP3 activation in a mtROS-dependent manner and as a result promoted viral clearance. [21] [27] Furthermore, Pink1 and Parkin deficiency in a model of polymicrobial sepsis induced inflammasome activation and appeared to be critical in host protection. [28] Consistent with these reports, there are also studies describing the loss of the autophagy protein Atg16L1 which induced the cleavage of IL-1β by caspases associated with NLRP3. [21] Many other proteins are known to modulate mitophagy. Some are cell-specific, for example, macrophages produce stress-induced proteins that are known to induce mitophagy followed by inhibition of NLRP3 inflammasome assembly. [21] [29] In general, it can be said that many pathological inflammatory responses are the result of an imbalance in the crosstalk between the inflammasome and the mitophagy.

Viral immune response

It is known that some viruses can modulate mitophagy (directly or indirectly) using different mechanisms and, as a result, cause a disbalance in the innate immune response. [21] mtDNA that exits damaged mitochondria acts as one of the triggers of type I interferon (IFN I) production. Some viruses can induce mitophagy and therefore inhibit the production of these crucial antiviral cytokines. There are reports of viral proteins directly or indirectly interacting with autophagy and mitophagy-associated proteins such as LC3 or Pink1-Parkin and usurping them to trigger mitophagy and subsequently inhibit IFN I responses. [21] [30]

Mitochondria is a dynamic structure regulating its morphology by context-dependent constant fission and fusion. Fission is crucial for mitophagy, as it cuts off a small mitochondrial part that can be further engulfed by the autophagosome. [31] The viruses Hepatitis B (HBV) and hepatitis C (HCV) take advantage of this mechanism by inducing mitochondrial fission and following mitophagy. HBV stimulates the phosphorylation of Drp1, a fission-promoting GTPase molecule, and the expression and recruitment of Parkin. HCV is known to promote mitophagy by inducing ROS production. Other viruses such as Human Parainfluenza (HPIV3) regulate host immune responses by clearing mitochondrial antiviral-signaling protein (MAVS) located in the outer mitochondrial membrane. There are specific proteins produced by HPIV3 that induce mitophagy in the infected cell, thus promoting MAVS degradation and the corresponding inhibition of IFN I production. The same strategy is used by the SARS-CoV-encoded protein ORF-9b, which triggers the degradation of several mitochondrial proteins, including MAVS. [32] [33]

Relation to disease

Cancer

As of 2020, the role of mitophagy in cancer is not fully understood. Some models of mitophagy, such as PINK1 or BNIP3-mediated mitophagy, have been associated with tumor suppression in humans and mice. Mitophagy associated with NIX, in contrast, is associated with tumor promotion. [34] In 1920 Otto Warburg observed that certain cancerous tumors display a metabolic shift towards glycolysis. This is referred to as the "Warburg effect", in which cancer cells produce energy via the conversion of glucose into lactate, even in the presence of oxygen (aerobic glycolysis). Despite nearly a century since it was first described, a lot of questions remained unanswered regarding the Warburg effect. Initially, Warburg attributed this metabolic shift to mitochondrial dysfunction in cancer cells. Further studies in tumor biology have shown that the increased growth rate in cancer cells is due to an overdrive in glycolysis (glycolytic shift), which leads to a decrease in oxidative phosphorylation and mitochondrial density. As a consequence of the Warburg effect, cancer cells would produce large amounts of lactate. The excess lactate is then released to the extracellular environment which results in a decrease in extracellular pH. This micro-environment acidification can lead to cellular stress, which would lead to autophagy. Autophagy is activated in response to a range of stimuli, including nutrient depletion, hypoxia, and activated oncogenes. However, it appears that autophagy can help in cancer cell survival under conditions of metabolic stress and it may confer resistance to anti-cancer therapies such as radiation and chemotherapy. Additionally, in the microenvironment of cancer cells, there is an increase in hypoxia-inducible transcription factor 1-alpha (HIF1A), which promotes expression of BNIP3, an essential factor for mitophagy. [35]

Parkinson's disease

Parkinson's disease is a neurodegenerative disorder pathologically characterized by death of the dopamine-producing neurons in the substantia nigra. There are several genetic mutations implicated in Parkinson's disease, including loss of function PINK1 [36] and Parkin. [9] Loss of function in either of these genes results in the accumulation of damaged mitochondria, and aggregation of proteins or inclusion bodies – eventually leading to neuronal death.

Mitochondria dysfunction is thought to be involved in Parkinson's disease pathogenesis. In spontaneous, usually aging related Parkinson's disease (non-genetically linked), the disease is commonly caused by dysfunctional mitochondria, cellular oxidative stress, autophagic alterations and the aggregation of proteins. These can lead to mitochondrial swelling and depolarization. It is important to keep the dysfunctional mitochondria regulated, because all of these traits could be induced by mitochondrial dysfunction and can induce cell death. [37] Disorders in energy creation by mitochondria can cause cellular degeneration, like those seen in the substantia nigra. [31]

Tuberculosis

Tuberculosis is a contagious disease caused by infection with the airborne pathogen Mycobacterium tuberculosis. Recent investigation has shown that chronic infection by Mycobacterium tuberculosis in the lungs or ex-vivo infection by non-pathogenic mycobacteria (M.bovis) elicits activation of the receptor-mediated pathway for mitophagy. Here the receptor mediated mitophagy pathways are elicited through NIX that gets upregulated during M. tuberculosis infection. Elicited NIX/BNIP3L receptor recruitment of LC3 molecules mediating formation of phagophore that engulf defective mitochondria directly [38]

Related Research Articles

<span class="mw-page-title-main">Autophagy</span> Cellular catabolic process in which cells digest parts of their own cytoplasm

Autophagy is the natural, conserved degradation of the cell that removes unnecessary or dysfunctional components through a lysosome-dependent regulated mechanism. It allows the orderly degradation and recycling of cellular components. Although initially characterized as a primordial degradation pathway induced to protect against starvation, it has become increasingly clear that autophagy also plays a major role in the homeostasis of non-starved cells. Defects in autophagy have been linked to various human diseases, including neurodegeneration and cancer, and interest in modulating autophagy as a potential treatment for these diseases has grown rapidly.

<span class="mw-page-title-main">Reactive oxygen species</span> Highly reactive molecules formed from diatomic oxygen (O₂)

In chemistry and biology, reactive oxygen species (ROS) are highly reactive chemicals formed from diatomic oxygen (O2), water, and hydrogen peroxide. Some prominent ROS are hydroperoxide (O2H), superoxide (O2-), hydroxyl radical (OH.), and singlet oxygen. ROS are pervasive because they are readily produced from O2, which is abundant. ROS are important in many ways, both beneficial and otherwise. ROS function as signals, that turn on and off biological functions. They are intermediates in the redox behavior of O2, which is central to fuel cells. ROS are central to the photodegradation of organic pollutants in the atmosphere. Most often however, ROS are discussed in a biological context, ranging from their effects on aging and their role in causing dangerous genetic mutations.

<span class="mw-page-title-main">Parkin (protein)</span>

Parkin is a 465-amino acid residue E3 ubiquitin ligase, a protein that in humans and mice is encoded by the PARK2 gene. Parkin plays a critical role in ubiquitination – the process whereby molecules are covalently labelled with ubiquitin (Ub) and directed towards degradation in proteasomes or lysosomes. Ubiquitination involves the sequential action of three enzymes. First, an E1 ubiquitin-activating enzyme binds to inactive Ub in eukaryotic cells via a thioester bond and mobilises it in an ATP-dependent process. Ub is then transferred to an E2 ubiquitin-conjugating enzyme before being conjugated to the target protein via an E3 ubiquitin ligase. There exists a multitude of E3 ligases, which differ in structure and substrate specificity to allow selective targeting of proteins to intracellular degradation.

<span class="mw-page-title-main">Phagosome</span>

In cell biology, a phagosome is a vesicle formed around a particle engulfed by a phagocyte via phagocytosis. Professional phagocytes include macrophages, neutrophils, and dendritic cells (DCs).

Carbonyl cyanide <i>m</i>-chlorophenyl hydrazone Chemical compound

Carbonyl cyanide m-chlorophenyl hydrazone is a chemical inhibitor of oxidative phosphorylation. It is a nitrile, hydrazone and protonophore. In general, CCCP causes the gradual destruction of living cells and death of the organism, although mild doses inducing partial decoupling have been shown to increase median and maximum lifespan in C. elegans models, suggesting a degree of hormesis. CCCP causes an uncoupling of the proton gradient that is established during the normal activity of electron carriers in the electron transport chain. The chemical acts essentially as an ionophore and reduces the ability of ATP synthase to function optimally. It is routinely used as an experimental uncoupling agent in cell and molecular biology, particularly in the study of mitophagy, where it was integral in discovering the role of the Parkinson's disease-associated ubiquitin ligase Parkin. Outside of its effects on mitochondria, CCCP may also disrupt lysosomal degradation during autophagy.

<span class="mw-page-title-main">MFN2</span> Protein-coding gene in the species Homo sapiens

Mitofusin-2 is a protein that in humans is encoded by the MFN2 gene. Mitofusins are GTPases embedded in the outer membrane of the mitochondria. In mammals MFN1 and MFN2 are essential for mitochondrial fusion. In addition to the mitofusins, OPA1 regulates inner mitochondrial membrane fusion, and DRP1 is responsible for mitochondrial fission.

<span class="mw-page-title-main">PINK1</span> Protein-coding gene in the species Homo sapiens

PTEN-induced kinase 1 (PINK1) is a mitochondrial serine/threonine-protein kinase encoded by the PINK1 gene.

<span class="mw-page-title-main">BNIP3</span> Protein-coding gene in the species Homo sapiens

BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 is a protein found in humans that is encoded by the BNIP3 gene.

<span class="mw-page-title-main">RHOT1</span> Protein-coding gene in the species Homo sapiens

Mitochondrial Rho GTPase 1 (MIRO1) is an enzyme that in humans is encoded by the RHOT1 gene on chromosome 17. As a Miro protein isoform, the protein facilitates mitochondrial transport by attaching the mitochondria to the motor/adaptor complex. Through its key role in mitochondrial transport, RHOT1 is involved in mitochondrial homeostasis and apoptosis, as well as Parkinson’s disease (PD) and cancer.

<span class="mw-page-title-main">RHOT2</span> Protein-coding gene in the species Homo sapiens

Mitochondrial Rho GTPase 2 is an enzyme that in humans is encoded by the RHOT2 gene. As a Miro protein isoform, the protein facilitates mitochondrial transport by attaching the mitochondria to the motor/adaptor complex. Through its key role in mitochondrial transport, RHOT2 is involved in mitochondrial homeostasis and apoptosis, as well as Parkinson’s disease (PD).

<span class="mw-page-title-main">TP53-inducible glycolysis and apoptosis regulator</span> Protein-coding gene in the species Homo sapiens

The TP53-inducible glycolysis and apoptosis regulator (TIGAR) also known as fructose-2,6-bisphosphatase TIGAR is an enzyme that in humans is encoded by the C12orf5 gene.

Immunogenic cell death is any type of cell death eliciting an immune response. Both accidental cell death and regulated cell death can result in immune response. Immunogenic cell death contrasts to forms of cell death that do not elicit any response or even mediate immune tolerance.

<span class="mw-page-title-main">MUL1</span> Protein-coding gene in the species Homo sapiens

Mitochondrial E3 ubiquitin protein ligase 1 (MUL1) is an enzyme that in humans is encoded by the MUL1 gene on chromosome 1. This enzyme localizes to the outer mitochondrial membrane, where it regulates mitochondrial morphology and apoptosis through multiple pathways, including the Akt, JNK, and NF-κB. Its proapoptotic function thus implicates it in cancer and Parkinson’s disease.

<span class="mw-page-title-main">Pathophysiology of Parkinson's disease</span> Medical condition

The pathophysiology of Parkinson's disease is death of dopaminergic neurons as a result of changes in biological activity in the brain with respect to Parkinson's disease (PD). There are several proposed mechanisms for neuronal death in PD; however, not all of them are well understood. Five proposed major mechanisms for neuronal death in Parkinson's Disease include protein aggregation in Lewy bodies, disruption of autophagy, changes in cell metabolism or mitochondrial function, neuroinflammation, and blood–brain barrier (BBB) breakdown resulting in vascular leakiness.

The mitochondrial unfolded protein response (UPRmt) is a cellular stress response related to the mitochondria. The UPRmt results from unfolded or misfolded proteins in mitochondria beyond the capacity of chaperone proteins to handle them. The UPRmt can occur either in the mitochondrial matrix or in the mitochondrial inner membrane. In the UPRmt, the mitochondrion will either upregulate chaperone proteins or invoke proteases to degrade proteins that fail to fold properly. UPRmt causes the sirtuin SIRT3 to activate antioxidant enzymes and mitophagy.

<span class="mw-page-title-main">Mitochondria associated membranes</span> Cellular structure

Mitochondria-associated membranes (MAM) represent a region of the endoplasmic reticulum (ER) which is reversibly tethered to mitochondria. These membranes are involved in import of certain lipids from the ER to mitochondria and in regulation of calcium homeostasis, mitochondrial function, autophagy and apoptosis. They also play a role in development of neurodegenerative diseases and glucose homeostasis.

Immunometabolism is a branch of biology that studies the interplay between metabolism and immunology in all organisms. In particular, immunometabolism is the study of the molecular and biochemical underpinninngs for i) the metabolic regulation of immune function, and ii) the regulation of metabolism by molecules and cells of the immune system. Further categorization includes i) systemic immunometabolism and ii) cellular immunometabolism. Immunometabolism includes metabolic inflammation:a chronic, systemic, low grade inflammation, orchestrated by metabolic deregulation caused by obesity or aging.

<span class="mw-page-title-main">Animal models of Parkinson's disease</span> Models used in Parkinsons disease research

Animal models of Parkinson's disease are essential in the research field and widely used to study Parkinson's disease. Parkinson's disease is a neurodegenerative disorder, characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of the dopamine neurons in the brain, results in motor dysfunction, ultimately causing the four cardinal symptoms of PD: tremor, rigidity, postural instability, and bradykinesia. It is the second most prevalent neurodegenerative disease, following Alzheimer's disease. It is estimated that nearly one million people could be living with PD in the United States.

Chantell Skye Evans is an American cell biologist who is a professor at Duke University. Her research looks to understand the dynamical processes of mitochondria and their role in neurodegenerative disease. In 2022, Popular Science named her as one of their "Brilliant 10" U.S. scientists and engineers.

<span class="mw-page-title-main">AMBRA1</span> Protein-coding gene

AMBRA1 is a protein that is able to regulate cancer cells through autophagy. AMBRA1 is described as a mechanism cells use to divide and there is new evidence demonstrating the role and impact of AMBRA1 as a candidate for the treatment of several disorders and diseases, including anticancer therapy. It is known to suppress tumors and plays a role in mitophagy and apoptosis. AMBRA1 can be found in the cytoskeleton and mitochondria and during the process of autophagy, it is localized at the endoplasmic reticulum. In normal conditions, AMBRA1 is dormant and will bind to BCL2 in the outer membrane. This relocation enables autophagosome nucleation. AMBRA1 protein is involved in several cellular processes and is involved in the regulation of the immune system and nervous system.

References

  1. ↑ Lewis, Margaret; Lewis, Warren (1915). "Mitochondria (and other cytoplamic structures) in tissue cultures" (PDF). American Journal of Anatomy. 17 (3): 339–401. doi:10.1002/aja.1000170304.
  2. ↑ Ashford, TP; Porter, KR (1962). "Cytoplasmic components of hepatic cell lysosomes". The Journal of Cell Biology. 12 (1): 198–202. doi:10.1083/jcb.12.1.198. PMC   2106008 . PMID   13862833.
  3. ↑ Beaulaton, J; Lockshin, KR (1977). "Ultrastructural study of the normal degeneration of the intersegmental muscles of Anthereae polyphemus and Manduca sexta (Insecta, Lepidoptera) with particular reference of cellular autophagy". Journal of Morphology. 154 (1): 39–57. doi:10.1002/jmor.1051540104. PMID   915948. S2CID   34266828.
  4. ↑ Scott, SV; Klionsky, DJ (1988). "Delivery of Proteins and organelles to the vacuole from the cytoplasm". Current Opinion in Cell Biology. 10 (4): 523–529. doi:10.1016/S0955-0674(98)80068-9. PMID   9719874.
  5. ↑ Youle, R; Narendra, D (2011). "Mechanisms of mitophagy". Nature Reviews Molecular Cell Biology. 12 (1): 9–14. doi:10.1038/nrm3028. PMC   4780047 . PMID   21179058.
  6. ↑ Kim, I; et al. (2007). "Selective degradation of mitochondria by mitophagy". Archives of Biochemistry and Biophysics. 462 (2): 245–256. doi:10.1016/j.abb.2007.03.034. PMC   2756107 . PMID   17475204.
  7. ↑ Correia-Melo C, Marques FD, Anderson R, Hewitt G, Hewitt R, Cole J, Carroll BM, Miwa S, Birch J, Merz A, Rushton MD, Charles M, Jurk D, Tait SW, Czapiewski R, Greaves L, Nelson G, Bohlooly-Y M, Rodriguez-Cuenca S, Vidal-Puig A, Mann D, Saretzki G, Quarato G, Green DR, Adams PD, von Zglinicki T, Korolchuk VI, Passos JF (2016). "Mitochondria are required for pro-ageing features of the senescent phenotype". The EMBO Journal. 35 (7): 724–42. doi:10.15252/embj.201592862. PMC   4818766 . PMID   26848154. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis.
  8. ↑ Jin, SM; Youle, RJ (2012). "PINK1- and Parkin-mediated mitophagy at a glance". J Cell Sci. 125 (4): 795–9. doi:10.1242/jcs.093849. PMC   3656616 . PMID   22448035.
  9. 1 2 Kitada, T; Asakawa, S; Hattori, N; et al. (1998). "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism". Nature. 392 (6676): 605–8. Bibcode:1998Natur.392..605K. doi:10.1038/33416. PMID   9560156. S2CID   4432261.
  10. 1 2 3 Lazarou M. "Keeping the immune system in check: a role for mitophagy. Immunol Cell Biol. 2014;
  11. 1 2 Kane, LA; Lazarou, M; Fogel, AI; et al. (2014). "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity". J Cell Biol. 205 (2): 143–53. doi:10.1083/jcb.201402104. PMC   4003245 . PMID   24751536.
  12. ↑ Narendra, D; Tanaka, A; Suen, DF; Youle, RJ (2009). "Parkin-induced mitophagy in the pathogenesis of Parkinson disease". Autophagy. 5 (5): 706–8. doi: 10.4161/auto.5.5.8505 . PMID   19377297.
  13. ↑ Jiang, Ziwen; Kuo, Yu-Hsuan; Arkin, Michelle R. (2023-11-07). "Synthetic autophagy receptor". Autophagy. doi: 10.1080/15548627.2023.2278954 . ISSN   1554-8627. PMID   37934826.
  14. ↑ Jiang, Ziwen; Kuo, Yu-Hsuan; Arkin, Michelle R. (2023-11-08). "Autophagy Receptor-Inspired Antibody-Fusion Proteins for Targeted Intracellular Degradation". Journal of the American Chemical Society. 145 (44): 23939–23947. doi:10.1021/jacs.3c05199. ISSN   0002-7863. PMC   10636752 . PMID   37748140.
  15. ↑ Saxton, William M.; Hollenbeck, Peter J. (2012). "The axonal transport of mitochondria". Journal of Cell Science. 125 (9): 2095–2104. doi:10.1242/jcs.053850. PMC   1533994 . PMID   16306220.
  16. ↑ Ashrafi G, Schlehe JS, Lavoie MJ, Schwartz TL (2014). "Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin". J Cell Biol. 206 (5): 655–70. doi:10.1083/jcb.201401070. PMC   4151150 . PMID   25154397.
  17. ↑ Davis CH, Kim KY, Bushong EA, Mills EA, Boassa D, Shih T, Kinebuchi M, Phan S, Zhou Y, Bihlmeyer NA, Nguyen JV, Jin Y, Ellisman MH, Marsh-Armstrong N (2014). "Transcellular degradation of axonal mitochondria". Proc Natl Acad Sci U S A. 111 (26): 9633–8. Bibcode:2014PNAS..111.9633D. doi: 10.1073/pnas.1404651111 . PMC   4084443 . PMID   24979790.
  18. 1 2 3 Tolkovsky, AM (2009). "Mitophagy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793 (9): 1508–15. doi: 10.1016/j.bbamcr.2009.03.002 . PMID   19289147.
  19. ↑ Kanki, T; et al. (2009). "Atg32 is a mitochondrial protein that confers selectivity during mitophagy". Dev Cell. 17 (1): 98–109. doi:10.1016/j.devcel.2009.06.014. PMC   2746076 . PMID   19619495.
  20. ↑ Vives-Bauza, C; Przedborski, S (2011). "Mitophagy: the latest problem for Parkinson's disease". Trends Mol Med. 17 (3): 158–65. doi:10.1016/j.molmed.2010.11.002. PMID   21146459.
  21. 1 2 3 4 5 6 Song, Yinjuan; Zhou, Yang; Zhou, Xiangmei (2020-11-25). "The role of mitophagy in innate immune responses triggered by mitochondrial stress". Cell Communication and Signaling. 18 (1): 186. doi: 10.1186/s12964-020-00659-x . ISSN   1478-811X. PMC   7687798 . PMID   33239048.
  22. ↑ Skendros, Panagiotis; Mitroulis, Ioannis; Ritis, Konstantinos (2018-09-04). "Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps". Frontiers in Cell and Developmental Biology. 6: 109. doi: 10.3389/fcell.2018.00109 . ISSN   2296-634X. PMC   6131573 . PMID   30234114.
  23. ↑ Hu, Chenchen; Xuan, Yuxin; Zhang, Xiyang; Liu, Yang; Yang, Shuya; Yang, Kun (October 2022). "Immune cell metabolism and metabolic reprogramming". Molecular Biology Reports. 49 (10): 9783–9795. doi:10.1007/s11033-022-07474-2. ISSN   1573-4978. PMC   9189272 . PMID   35696048.
  24. 1 2 Gkikas, Ilias; Palikaras, Konstantinos; Tavernarakis, Nektarios (2018). "The Role of Mitophagy in Innate Immunity". Frontiers in Immunology. 9: 1283. doi: 10.3389/fimmu.2018.01283 . ISSN   1664-3224. PMC   6008576 . PMID   29951054.
  25. ↑ Bhatia, Divya; Chung, Kuei-Pin; Nakahira, Kiichi; Patino, Edwin; Rice, Michelle C.; Torres, Lisa K.; Muthukumar, Thangamani; Choi, Augustine Mk; Akchurin, Oleh M.; Choi, Mary E. (2019-12-05). "Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis". JCI Insight. 4 (23): e132826, 132826. doi:10.1172/jci.insight.132826. ISSN   2379-3708. PMC   6962025 . PMID   31639106.
  26. 1 2 Yuk, Jae-Min; Silwal, Prashanta; Jo, Eun-Kyeong (2020-07-01). "Inflammasome and Mitophagy Connection in Health and Disease". International Journal of Molecular Sciences. 21 (13): 4714. doi: 10.3390/ijms21134714 . ISSN   1422-0067. PMC   7370205 . PMID   32630319.
  27. ↑ Li, Jian; Ma, Chunmei; Long, Fei; Yang, Dongxue; Liu, Xue; Hu, Yingchao; Wu, Chunyan; Wang, Bingwei; Wang, Min; Chen, Yunzi; Liu, Genyan; Moynagh, Paul N.; Zhou, Jiawei; Peng, Tao; Yang, Shuo (2019-06-28). "Parkin Impairs Antiviral Immunity by Suppressing the Mitochondrial Reactive Oxygen Species-Nlrp3 Axis and Antiviral Inflammation". iScience. 16: 468–484. Bibcode:2019iSci...16..468L. doi:10.1016/j.isci.2019.06.008. ISSN   2589-0042. PMC   6593176 . PMID   31229895.
  28. ↑ Cho, Dong-Hyung; Kim, Jin Kyung; Jo, Eun-Kyeong (2020-01-31). "Mitophagy and Innate Immunity in Infection". Molecules and Cells. 43 (1): 10–22. doi:10.14348/molcells.2020.2329. PMC   6999710 . PMID   31999918.
  29. ↑ Lu, Chunfeng; Jiang, Yiming; Xu, Wenxuan; Bao, Xiaofeng (2023-02-25). "Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases". Cell Death & Disease. 14 (2): 160. doi:10.1038/s41419-023-05669-4. ISSN   2041-4889. PMC   9968343 . PMID   36841824.
  30. ↑ Ren, Zhihua; Zhang, Xiaojie; Ding, Ting; Zhong, Zhijun; Hu, Hui; Xu, Zhiwen; Deng, Junliang (2020). "Mitochondrial Dynamics Imbalance: A Strategy for Promoting Viral Infection". Frontiers in Microbiology. 11: 1992. doi: 10.3389/fmicb.2020.01992 . ISSN   1664-302X. PMC   7472841 . PMID   32973718.
  31. 1 2 Arduíno, DM; Esteves, AR; Cardoso, SM (2011). "Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty". Parkinson's Disease. 2011: 767230. doi: 10.4061/2011/767230 . PMC   3043324 . PMID   21403911.
  32. ↑ Fu, Cheng; Cao, Nan; Liu, Wenjun; Zhang, Zilin; Yang, Zihui; Zhu, Wenhui; Fan, Shuangqi (2022-12-16). "Crosstalk between mitophagy and innate immunity in viral infection". Frontiers in Microbiology. 13. doi: 10.3389/fmicb.2022.1064045 . ISSN   1664-302X. PMC   9800879 . PMID   36590405.
  33. ↑ Wang, Hongna; Zheng, Yongfeng; Huang, Jieru; Li, Jin (2021). "Mitophagy in Antiviral Immunity". Frontiers in Cell and Developmental Biology. 9: 723108. doi: 10.3389/fcell.2021.723108 . ISSN   2296-634X. PMC   8446632 . PMID   34540840.
  34. ↑ MacLeod, Kay F. (2020). "Mitophagy and Mitochondrial Dysfunction in Cancer". Annual Review of Cancer Biology. 4 (1): 41–60. doi: 10.1146/annurev-cancerbio-030419-033405 .
  35. ↑ Pavlides, S; et al. (2012). "Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis". Antioxidants & Redox Signaling. 16 (11): 1264–1284. doi:10.1089/ars.2011.4243. PMC   3324816 . PMID   21883043.
  36. ↑ Valente, EM; Abou-sleiman, PM; Caputo, V; et al. (2004). "Hereditary early-onset Parkinson's disease caused by mutations in PINK1" (PDF). Science. 304 (5674): 1158–60. Bibcode:2004Sci...304.1158V. doi:10.1126/science.1096284. PMID   15087508. S2CID   33630092.
  37. ↑ Esteves, AR; Arduíno, DM; Silva, DF; Oliveira, CR; Cardoso, SM (2011). "Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD". Parkinson's Disease. 2011: 693761. doi: 10.4061/2011/693761 . PMC   3026982 . PMID   21318163.
  38. ↑ Mahla, RS; et al. (2021). "NIX-mediated mitophagy regulate metabolic reprogramming in phagocytic cells during mycobacterial infection". Lancet Infectious Diseases. 126: 102046. doi:10.1016/j.tube.2020.102046. PMID   33421909. S2CID   231437641.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.